Make scientific figures in minutes
Create publication-quality figures with pre-made icons and templates, all from BioRender's web-based software
Use Icons In The App
Try a synonym, or sign up to request an icon from the app.
Metabolism (ADMET, symbol)
[{"image":"https://icons.cdn.biorender.com/w75xh75/67f5951e8036a7aacbd4d1a3/67f594d28036a7aacbd4d172.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67f5951e8036a7aacbd4d1a3/67f594d28036a7aacbd4d172.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67f5951e8036a7aacbd4d1a4/67f594d28036a7aacbd4d172.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67f5951e8036a7aacbd4d1a4/67f594d28036a7aacbd4d172.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67f5951e8036a7aacbd4d1a5/67f594d28036a7aacbd4d172.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67f5951e8036a7aacbd4d1a5/67f594d28036a7aacbd4d172.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67f5951e8036a7aacbd4d1a6/67f594d28036a7aacbd4d172.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67f5951e8036a7aacbd4d1a6/67f594d28036a7aacbd4d172.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67f5951e8036a7aacbd4d1a7/67f594d28036a7aacbd4d172.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67f5951e8036a7aacbd4d1a7/67f594d28036a7aacbd4d172.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67f5951e8036a7aacbd4d1a8/67f594d28036a7aacbd4d172.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67f5951e8036a7aacbd4d1a8/67f594d28036a7aacbd4d172.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67f5951e8036a7aacbd4d1a9/67f594d28036a7aacbd4d172.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67f5951e8036a7aacbd4d1a9/67f594d28036a7aacbd4d172.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67f5951e8036a7aacbd4d1aa/67f594d28036a7aacbd4d172.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67f5951e8036a7aacbd4d1aa/67f594d28036a7aacbd4d172.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67f5951e8036a7aacbd4d1ab/67f594d28036a7aacbd4d172.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67f5951e8036a7aacbd4d1ab/67f594d28036a7aacbd4d172.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67f5951e8036a7aacbd4d1ac/67f594d28036a7aacbd4d172.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67f5951e8036a7aacbd4d1ac/67f594d28036a7aacbd4d172.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67f5951e8036a7aacbd4d1ad/67f594d28036a7aacbd4d172.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67f5951e8036a7aacbd4d1ad/67f594d28036a7aacbd4d172.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67f5951e8036a7aacbd4d1ae/67f594d28036a7aacbd4d172.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67f5951e8036a7aacbd4d1ae/67f594d28036a7aacbd4d172.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67f5951e8036a7aacbd4d1af/67f594d28036a7aacbd4d172.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67f5951e8036a7aacbd4d1af/67f594d28036a7aacbd4d172.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67f5951e8036a7aacbd4d1b0/67f594d28036a7aacbd4d172.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67f5951e8036a7aacbd4d1b0/67f594d28036a7aacbd4d172.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67f5951e8036a7aacbd4d1b1/67f594d28036a7aacbd4d172.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67f5951e8036a7aacbd4d1b1/67f594d28036a7aacbd4d172.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67f5951e8036a7aacbd4d1b2/67f594d28036a7aacbd4d172.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67f5951e8036a7aacbd4d1b2/67f594d28036a7aacbd4d172.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67f5951e8036a7aacbd4d1b3/67f594d28036a7aacbd4d172.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67f5951e8036a7aacbd4d1b3/67f594d28036a7aacbd4d172.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67f5951e8036a7aacbd4d1b4/67f594d28036a7aacbd4d172.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67f5951e8036a7aacbd4d1b4/67f594d28036a7aacbd4d172.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67f5951e8036a7aacbd4d1b5/67f594d28036a7aacbd4d172.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67f5951e8036a7aacbd4d1b5/67f594d28036a7aacbd4d172.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67f5951e8036a7aacbd4d1b6/67f594d28036a7aacbd4d172.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67f5951e8036a7aacbd4d1b6/67f594d28036a7aacbd4d172.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67f5951e8036a7aacbd4d1b7/67f594d28036a7aacbd4d172.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67f5951e8036a7aacbd4d1b7/67f594d28036a7aacbd4d172.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67f5951e8036a7aacbd4d1b8/67f594d28036a7aacbd4d172.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67f5951e8036a7aacbd4d1b8/67f594d28036a7aacbd4d172.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67f5951e8036a7aacbd4d1b9/67f594d28036a7aacbd4d172.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67f5951e8036a7aacbd4d1b9/67f594d28036a7aacbd4d172.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67f5951e8036a7aacbd4d1ba/67f594d28036a7aacbd4d172.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67f5951e8036a7aacbd4d1ba/67f594d28036a7aacbd4d172.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67f5951e8036a7aacbd4d1bb/67f594d28036a7aacbd4d172.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67f5951e8036a7aacbd4d1bb/67f594d28036a7aacbd4d172.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67f5951e8036a7aacbd4d1bc/67f594d28036a7aacbd4d172.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67f5951e8036a7aacbd4d1bc/67f594d28036a7aacbd4d172.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67f5951e8036a7aacbd4d1bd/67f594d28036a7aacbd4d172.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67f5951e8036a7aacbd4d1bd/67f594d28036a7aacbd4d172.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67f5951e8036a7aacbd4d1be/67f594d28036a7aacbd4d172.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67f5951e8036a7aacbd4d1be/67f594d28036a7aacbd4d172.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67f5951e8036a7aacbd4d1bf/67f594d28036a7aacbd4d172.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67f5951e8036a7aacbd4d1bf/67f594d28036a7aacbd4d172.png"}]
Use this icon in BioRender along with 1000s of others to make your next science figure in minutes
.png)
SIGN UP FREEKeywords
admet,absorption,Distribution,Metabolism,Excretion
Toxicity,drug discovery,drug development,toxicology,pharmacokinetics,drug candidate,drug assessment,drug distribution,drug metabolism,hepatic metabolism,liver metabolism,liver drug metabolism,first-pass metabolism,metabolic clearance,drug biotransformation,CYP450 enzymes,cytochrome P450,drug detoxification,phase I metabolism,phase II metabolism,drug enzymatic breakdown,xenobiotic metabolism,liver pharmacology,hepatic clearance,liver drug clearance,drug metabolic pathways,drug metabolic stability,drug inactivation,metabolic degradation,microsomal enzymes,metabolic rate,drug elimination pathways,hepatic microsomes,metabolism modeling,biotransformation pathways,schematic,symbol,symbolic,sign,icon,iconography,mark,signify,simple,content-refinement-AI-expansion,admet,absorption,drug discovery
Image types
BioRender icons and templates meet journal, grant, and copyright standards. For AI-generated figures, policies vary. Learn More
Related Categories
Join 1,500,000 other scientists on BioRender
Sign up for your free account and start creating scientific figures faster today
FAQs
What is BioRender?
Can I use this icon in a BioRender figure or scientific illustration?
